Updates are available Correction dated 2026-01-19
Click to view Correction: https://doi.org/10.1007/s10072-025-08745-z
-
Authors
Aiello, Edoardo Nicolò https://orcid.org/0000-0001-8902-7733
Curti, Beatrice
De Luca, Giulia
Moreschi, Arianna
Crispiatico, Valeria
Maranzano, Alessio
Menichelli, Alina
Cattaruzza, Tatiana
Manganotti, Paolo
Silani, Vincenzo
Ticozzi, Nicola
Verde, Federico
Poletti, Barbara
-
Funding
Funding for this research was provided by:
Ministero della Salute (Ministero della Salute)
- License Information
-
More Information
Article History
Received: 12 August 2025
Accepted: 28 September 2025
First Online: 24 October 2025
Change Date: 13 December 2025
Change Type: Update
Change Details: The original online version of this article was revised: In the original version of the manuscript, published version of Figure 1 misses some labels within the figure. The original article has been corrected.
Change Date: 19 January 2026
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10072-025-08745-z
Declarations
:
: Participants provided informed consent. This study was approved by the Ethics Committee of IRCCS Istituto Auxologico Italiano (I.D.: 23C308) and was conducted in accordance with the Declaration of Helsinki.
: E.N.A. has edited the official manual of the Italian version of the Telephone Interview for Cognitive Status (TICS) on behalf of Giunti Psychometrics and perceive royalties from Giunti Psychometrics when such a manual is purchased. Giunti Psychometrics holds the copyright of the Italian TICS. B.P. is Associate Editor for Frontiers in Neuroscience ; she received compensation for consulting services and/or speaking activities from Liquidweb S.r.l. V.S. received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb S.r.l., Novartis Pharma AG, Amylyx Pharmaceuticals, Biogen, and Zambon Biotech SA; he receives or has received research supports from the Italian Ministry of Health, AriSLA, and E-Rare Joint Transnational Call; he is in the Editorial Board of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration , European Neurology , American Journal of Neurodegenerative Disease , Frontiers in Neurology , and Exploration of Neuroprotective Therapy . N.T. received compensation for consulting services and/or speaking fees from Amylyx Pharmaceuticals, Biogen, Italfarmaco, and Zambon Biotech SA. He is Associate Editor for Frontiers in Aging Neuroscience . F.V. is Associate Editor of Journal of Alzheimer’s Disease . E.N.A. serves as an Editorial Board Member for BMC Neurology The other Authors have nothing to declare.
